“Targets for Tomorrow” Workshop at GRC in Italy July 2013

We invite you to join us for the “Targets for Tomorrow” satellite workshop hosted by the WGND Biology/Targets Subgroup on Monday, July 22, 2013 from 2 p.m. to 4:30 p.m. at the Renaissance Tuscany Il Ciocco Resort, Lucca (Barga), Italy. The workshop is held in conjunction with the Gordon Conference on TB Drug Development (July 21-26). The objectives of the meeting are to:

  • Allow key entities involved strategically in TB drug discovery to present their views of the needs, directions and targets for tomorrow to the research community
  • Discuss the puzzling finding of ‘promiscuous targets’
  • Set a priority list of what constitutes good targets and what does not to develop a universal “go/no go” checklist for targets
“Targets For Tomorrow” Satellite Workshop
Workshop Chair: Thomas Dick
2:00 p.m.-3:15pm: Needs & directions in TB drug discovery–Leader: Petros KarakousisSession Speakers:
  • Barbara Laughon (NIAID/NIH)
  • Ken Duncan (Bill & Melinda Gates Foundation)
  • Anna Upton (TB Alliance)
  • Alfonso Mendoza-Losana (GlaxoSmithKline)
  • Petros Karakousis (Johns Hopkins)
3:15-3:30pm: Break
3:30-4:30pm: ‘Promiscuous targets’–Leader: Tanya ParishDiscussion Topics:
  • What makes a good target—Speaker: Bavesh Kana
  • Results from current target ID efforts– Speaker: Dirk Schnappinger
  • Are promiscuous targets good or bad– Speaker: TBD
  • Best approaches to target-based screening—Speaker: Helena Boshoff

Light refreshments will be served.

If you plan on attending the satellite workshop, please RSVP by e-mailing

More News
30 Mar 2021
Médecins Sans Frontières (MSF) published a press release on World TB Day 2021 announcing their clinical trial, TB-Practecal , investigating novel treatment for MDR-TB has stopped enrolling earlier than originally planned due to promising results. The trial's independent data safety and monitoring...
3 Feb 2021
Last week, the World Health Organization (WHO) held a consultation to discuss the definition of extensively drug resistant (XDR) tuberculosis. The meeting was held to discuss novel treatment regimens and diagnostics for drug-resistant TB and determine its impact on the definition of XDR-TB. The...
10 Dec 2020
The Stop TB Partnership Working Group on New TB Vaccines (WGNV), Working Group on New TB Drugs (WGND), and New Diagnostics Working Group (NDWG) are developing an online course specifically designed for advocates and affected communities to provide a base of knowledge in TB research and to generate...